Skip to main content
FinSpry Logo
FinSpry
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$4.16-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Oramed Pharmaceuticals (ORMP) Stock Price & Financial Analysis

Oramed Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.00 - $4.09
52-Week High$5.19
52-Week Low$1.98
Open$4.01
Volume161.09K
Average Volume (3M)405.66K
Market Cap170.52M
Shares Outstanding42.42M
P/E Ratio (TTM)1.56
Price to Book (P/B)0.86
EV/EBITDA2.00
50-Day MA$4.14
200-Day MA$3.36
52-Week Change91.04%
Annual Dividend$0.25
Dividend Yield6.17%
Payout Ratio9.65%
Last Dividend Ex-DateJan 16, 2026

Frequently Asked Questions About Oramed Pharmaceuticals

What is the current stock price for ORMP?

As of the latest trading session, ORMP stock trades at $4.02. The 52-week range is $1.98–$5.19, with a day range of $4.00–$4.08.

What is the P/E ratio for ORMP?

Oramed Pharmaceuticals's trailing P/E ratio is 1.6, meaning investors pay $1.6 for every $1 of annual earnings. Oramed Pharmaceuticals operates in the Healthcare sector.

Does ORMP pay dividends?

Yes, Oramed Pharmaceuticals pays a 6.17% annual dividend yield ($0.25 per share). The payout ratio is 9.7%. The last ex-dividend date was 2026-01-16.

What do analysts recommend for ORMP?

Analyst ratings and recommendations for ORMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ORMP?

Oramed Pharmaceuticals's market capitalization is $170.5M, classifying it as a micro-cap company. Oramed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.